Julio César Aguilar-Rubido

5PUBLICATIONS
8CO-AUTHORS
Climate change processesGene and molecular therapyPreventative health careNanotoxicology, health and safetyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 26, 2026
Preventive and Therapeutic Vaccination for COVID-19 Using NASVAC.

|Jan 13, 2025
HeberNasvac: Development and Application in the Context of Chronic Hepatitis B.

Julio C Aguilar, Sheikh Mf Akbar, Mamun Al-Mahtab

|Feb 14, 2022
Innate Immune Stimulation Should not be Overlooked in Post-exposure Prophylaxis and Early Therapy for Coronavirus Infections.

Julio C Aguilar-Rubido, Eduardo Pentón-Arias, Sheikh Mohammad Fazle Akbar

|Nov 17, 2021
HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis.

Yoel A Fleites, Jorge Aguiar, Zurina Cinza

|Mar 29, 2021
Cuban Prophylactic and Therapeutic Vaccines for Controlling Hepatitis B.

Eduardo Pentón-Arias, Julio César Aguilar-Rubido

Pageof 1

Frequent Collaborators

3 joint publications

Mamun Al-Mahtab

2 joint publications

Eduardo Pentón-Arias

1 joint publications

Sheikh Mohammad Fazle Akbar

1 joint publications

Sheikh Mf Akbar